Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
about
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesEmerging methods for disease monitoring in malignant gliomasRecent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsDiffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumorsProtein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapyMR Imaging Biomarkers in Oncology Clinical TrialsPerfusion MRI: the five most frequently asked clinical questions.Functional imaging in adult and paediatric brain tumours.Pseudoprogression in high-grade glioma.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Advanced MR Imaging in Neuro-oncology.Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.[Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme].Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.Pseudoprogression: relevance with respect to treatment of high-grade gliomas.Neuroradiological response criteria for high-grade gliomas.Central nervous system cancersSurvival analysis of patients with high-grade gliomas based on data mining of imaging variables.Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?sfDM: Open-Source Software for Temporal Analysis and Visualization of Brain Tumor Diffusion MR Using Serial Functional Diffusion Mapping.Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.Evaluation of early imaging response criteria in glioblastoma multiforme.In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T.A preliminary quantitative proteomic analysis of glioblastoma pseudoprogressionPost-treatment imaging of high-grade gliomasIntegrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis.Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment.MR-guided radiation therapy: transformative technology and its role in the central nervous system.Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed GlioblastomaMRI perfusion in determining pseudoprogression in patients with glioblastoma.The promise of dynamic contrast-enhanced imaging in radiation therapySerial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics
P2860
Q26743358-F1CB5075-F88F-4D87-9BB4-B3DCEF4D1F9EQ27023823-42B64B65-7C08-430E-9A32-037273FED78EQ28066044-34C08328-597F-4C92-A5E1-885A31093225Q28067114-CB55D52F-06BA-4B49-90B9-25574F9B9779Q28279046-8D00767A-23A8-41EF-AE45-58C63E1824A1Q30364608-8BBAD441-D04E-4E29-93C5-FC8546CB0D8EQ30416198-FA88D212-9140-47FF-A4E4-E4CF27ABCD11Q30577397-E3D97439-D6D5-4B48-BF13-BA8B896253CDQ30578798-0516F762-94CE-4B32-B385-B90DE75F4222Q30653828-C63EAB87-B2EC-42A5-92FC-EBEDC2552EDDQ30818733-2AAEE752-A541-4A5C-BC4B-854B7AEE93ADQ30847284-40404C00-AF06-4D28-A883-32F48C4B34B2Q30907831-D571D786-07D8-4129-9477-A4EF8C3059D0Q30938805-4958F06B-EB85-4E4A-8A0E-63E95DD68B9CQ30983681-0E7F8DD3-F19D-4C5F-BE8F-38DB4CA36C95Q33698886-F7FBA4C1-A635-4984-B311-A831E879FDD5Q33818313-F4FE07F7-667E-4CE0-9AE1-A5B869A86FD2Q33843085-86636E06-9130-42E1-85C5-17F9CF9BDF3EQ33905441-F507F7C8-A588-4B4F-B712-10C1CEC6EBCAQ33935125-F532C851-D7C5-4812-A637-92A83962C55BQ34014740-57A015DA-1C0F-4151-9287-9DB02DD4A08AQ34155776-411BDBC6-6E4A-4D31-8AEB-C63892034522Q34256394-B7BD0837-1892-427C-AA54-A43319E69EBAQ35042226-19E7F794-C968-41B9-906B-00DB1B287B1FQ35115962-19524892-FD89-42A1-AEF9-C213B39373DBQ35133246-5FE3A498-8CDC-421A-A573-40314B1CA1E2Q35289895-67E8EC94-4C66-43F3-A864-4DCABAF568ADQ35353492-B48B185A-F8C4-40B0-9EA7-77BE2A4B3B2CQ35368468-DABAA291-FD7D-46ED-AB1E-C48423642236Q35568711-C8A14194-73F7-4F48-B64E-5F18AF008533Q35598954-9E5F13FB-7DE2-4CFD-A20F-FDB7E610D8B7Q35771783-EC4C92F1-FBC6-4D7D-8DA8-3275CAD4C518Q36019924-3DD1E258-7273-4CD8-8E37-4481645D41B2Q36275542-0775D8DC-DC97-4A4F-B702-83A0172342A1Q36336361-BA9AF6DC-49B8-40C7-B7FD-3A148650AEDBQ36361484-06735935-DE1D-4E0C-8957-D285476CBAC7Q36424068-A79007FB-3B2A-4208-B8C1-D1B7E80BFF3CQ36585386-BDADD8B4-07AA-4346-AF99-BA37233B61AAQ36747134-4D4C00AD-F327-4570-BB08-5DBA0023ED9EQ37021537-D31758AF-83C0-436A-BB0E-5A51F1044DFB
P2860
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Parametric response map as an ...... gression in high-grade glioma.
@ast
Parametric response map as an ...... gression in high-grade glioma.
@en
Parametric response map as an ...... gression in high-grade glioma.
@nl
type
label
Parametric response map as an ...... gression in high-grade glioma.
@ast
Parametric response map as an ...... gression in high-grade glioma.
@en
Parametric response map as an ...... gression in high-grade glioma.
@nl
prefLabel
Parametric response map as an ...... gression in high-grade glioma.
@ast
Parametric response map as an ...... gression in high-grade glioma.
@en
Parametric response map as an ...... gression in high-grade glioma.
@nl
P2093
P2860
P356
P1476
Parametric response map as an ...... gression in high-grade glioma.
@en
P2093
Alnawaz Rehemtulla
Brian D Ross
Charles R Meyer
Christina Tsien
Craig J Galbán
Daniel A Hamstra
Larry Junck
Theodore Lawrence
Timothy D Johnson
P2860
P304
P356
10.1200/JCO.2009.25.3971
P407
P577
2010-04-05T00:00:00Z